CSBR
CSBR
NASDAQ · Life Sciences Tools & Services

Champions Oncology Inc

$4.93
+0.03 (+0.61%)
As of Sep 28, 10:23 PM ET ·
Financial Highlights (FY 2026)
Revenue
59.19M
Net Income
-1,169,628
Gross Margin
48.0%
Profit Margin
-2.0%
Rev Growth
+3.3%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 48.0% 48.0% 61.8% 61.8%
Operating Margin -1.9% -1.7% 20.5% 17.5%
Profit Margin -2.0% -1.9% 14.6% 15.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 59.19M 57.28M 19.71M 19.48M
Gross Profit 28.41M 27.49M 12.17M 12.03M
Operating Income -1,136,359 -989,763 4.04M 3.42M
Net Income -1,169,628 -1,018,741 2.89M 3.05M
Gross Margin 48.0% 48.0% 61.8% 61.8%
Operating Margin -1.9% -1.7% 20.5% 17.5%
Profit Margin -2.0% -1.9% 14.6% 15.7%
Rev Growth +3.3% +3.3% +2.4% -6.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 720.1K 720.1K 33.95M 38.63M
Total Equity 33.03M 33.03M 59.74M 52.97M
D/E Ratio 0.02 0.02 0.57 0.73
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 235.6K 216.6K 6.10M 5.64M
Free Cash Flow — — 2.36M 1.92M